{"cluster": 49, "subcluster": 35, "abstract_summ": "In this review, the outbreak of 2019-nCoV in China, the need for rapid vaccine development, and the potential of a plant system for biopharmaceutical development are discussed.In the past 6 years, we have accumulated rich experience in dealing with H7N9, especially in terms of virus tracing, epidemiological research, key site mutation monitoring, critical disease mechanisms, clinical treatment, and vaccine development.To fully document the research progress concerning H7N9, we reviewed the clinical and epidemiological characteristics of H7N9, the key gene mutations of the virus, and H7N9 vaccine, thus providing a scientific basis for further monitoring and prevention of H7N9 influenza epidemics.Abstract At the end of December 2019, a novel coronavirus, 2019-nCoV, caused an outbreak of pneumonia spreading from Wuhan, Hubei province, to the whole country of China, which has posed great threats to public health and attracted enormous attention around the world.This virus is responsible for the ongoing outbreak that causes severe respiratory illness and pneumonia-like infection in humans.", "title_summ": "Research progress on human infection with avian influenza H7N9Emergence of Novel Coronavirus 2019-nCoV: Need for Rapid Vaccine and Biologics DevelopmentPathogenicity and transmissibility of 2019-nCoV\u2014A quick overview and comparison with other emerging viruses2019-nCoV - Towards a 4th generation vaccineThe epidemic of 2019-novel-coronavirus (2019-nCoV) pneumonia and insights for emerging infectious diseases in the future", "title_abstract_phrases": "To fully document the research progress concerning H7N9, we reviewed the clinical and epidemiological characteristics of H7N9, the key gene mutations of the virus, and H7N9 vaccine, thus providing a scientific basis for further monitoring and prevention of H7N9 influenza epidemics.In the past 6 years, we have accumulated rich experience in dealing with H7N9, especially in terms of virus tracing, epidemiological research, key site mutation monitoring, critical disease mechanisms, clinical treatment, and vaccine development.Emergence of Novel Coronavirus 2019-nCoV: Need for Rapid Vaccine and Biologics DevelopmentNovel Coronavirus (2019-nCoV) is an emerging pathogen that was first identified in Wuhan, China in late December 2019.Research progress on human infection with avian influenza H7N9Since the first case of novel H7N9 infection was reported, China has experienced five epidemics of H7N9.In this review, the outbreak of 2019-nCoV in China, the need for rapid vaccine development, and the potential of a plant system for biopharmaceutical development are discussed."}